A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity
A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 414 participants.
Also called NCT06037252
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 414 participants
- Sponsor
- Registry
-
NCT06037252
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- United States, Argentina, Mexico, Türkiye
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06037252. Randomized; double masking; primary purpose treatment. Start 2023-09-21 (actual); primary completion 2026-01-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity
- Condition
- Type 2 Diabetes
- Condition
- Obesity
- Intervention (Drug)
- Tirzepatide
- Intervention (Drug)
- Placebo
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct06037252- Content hash
e6674c285e0a81081343560d62859b25a52beb8589df3dae0e25fd6fc04c8c38